Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

1.62
BATS BZX Real-Time Price
As of 3:56pm ET
 -0.015 / -0.92%
Today’s Change
0.74
Today|||52-Week Range
1.92
+20.52%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.63
Today’s open1.64
Day’s range1.57 - 1.64
Volume10,103
Average volume (3 months)926,417
Market cap$239.6M
Dividend yield--
Data as of 3:56pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-36.84%
Earnings growth (this year)+19.23%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-26.66%
P/E ratioNM
Price/Sales12.72
Price/Book27.62

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.11-2.00%
SNDXSyndax Pharmaceutica...+0.36+3.30%
NBRVNabriva Therapeutics...-0.09-1.02%
ADXSAdvaxis Inc-0.10-1.66%
Data as of 3:56pm ET, 08/21/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$14.0M
Annual profit (last year)-$34.5M
Net profit margin-246.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts